Alliqua BioMedical to acquire Adynxx, forming new clinical-stage pharmaceutical leader
Pennsylvania-based Alliqua BioMedical has announced a significant merger with San Francisco’s Adynxx, aiming to establish a clinical-stage pharmaceutical entity dedicated to non-opioid pain management therapies. This strategic move promises to revolutionize pain treatment by developing disease-modifying solutions. Under the terms of the merger, Adynxx stockholders will emerge as the primary owners of Alliqua’s outstanding common […]